Neuroinflammation in early and late onset Alzheimer´s disease: a multimodal analysis
Year: 2018
Type: dissertation
Study design: Observational Study
Abstract: Alzheimer´s disease (AD) is a chronic neurodegenerative disorder and is the most common cause of dementia. The two major neuropathological hallmarks of the disease are senile plaques, mainly composed of extracellular deposits of amyloid β (Aβ), and neurofibrillary tangles, consisting of intracellular aggregates of aberrantly phosphorylated tau protein. This is accompanied by synaptic loss and neuronal loss, dendritic and axonal changes, and inflammatory reactive lesions. Cumulative data suggests that neuroinflammation plays a prominent role in AD pathogenesis and ageassociated dysregulation of the neuroimmune system. From a clinical point of view, despite the resemblance of neuropathological, there are important differences between the group of patients with sporadic early onset (<65 years old) and late onset Alzheimer's disease (>65 years old). Thus, it seems important to understand the agedependent relationship between neuroinflammation and the underlying biology of AD in order to identify potential explanations for clinical heterogeneity, interpret biomarkers and to promote the best treatment for different clinical AD phenotypes. In this thesis, it is first demonstrated that microglia activation has particular characteristics associated to AD that are distinct from frontotemporal dementia (FTD), another type of neurodegenerative dementia studied in this work. Subsequently, we found that the neuroinflammatory pathological markers (microglia activation and astrogliosis) in late stage AD human tissue have an overall similar pattern in both early and late onset AD, despite the greater severity of the pathological markers in the younger group. In a prospective clinical study, we showed a pro- and anti-inflammatory immune dysregulation in the cerebrospinal fluid cytokines in patients with AD and FTD, together with findings of particular signatures for each disorder. Furthermore, our results supports a possible protective role of inflammatory upregulation in early disease stages and suggest an age effect on IP-10 mediated pathogenesis in AD. The studies presented in this thesis call for a reappraisal of aging as a modulating factor in sporadic AD associated inflammation and highlight the idea that inflammation in this context is not exclusively detrimental or beneficial, but has to be fine-tuned. The study of this delicate balance in the different ages will be important to understand treatment efficacy, namely immunotherapeutic approaches, in clinical trials.
Author: Ricardo Taipa
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Keywords: Alzheimer's disease, neuroinflammation, early-onset Alzheimer's disease, late-onset Alzheimer's disease, microglial activation, astrocyte activation, frontotemporal dementia, cerebrospinal fluid cytokines, immune dysregulation, aging, CXCL10, amyloid-beta, tau protein, neuroimmune system, immunotherapy
Open Access status: green
Awards: G1167214205, G1516346500, G1578237752, G1763632427, G2440504136, G3326568298, G3786582701, G3840324753, G4316116677, New avenues for the development of personalized medical interventions for neurological, oncologic and surgical disorders – “PersonalizedNOS”, G5224927334, UID/Multi/50026 .: ICVS/3B?s - Laboratório Associado, Instituto de Ciências da Vida e da Saúde / Grupo de Investigação em Biomateriais, Bio, G7584003722, G96847669
OpenAlex ID: W2891229216
